Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 30th June, 2022. Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window
Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons shall remain closed from July 01, 2022 till 48 (Forty Eight) hours after the conclusion of the Meeting of the Board of Directors of the Company to be held to consider and approve the Un-Audited Financial Results of the Company for the quarter and three months ended June 30, 2022. The date and venue of Board Meeting for the aforesaid purpose shall be intimated to you in due course. Please take the above on records and acknowledge the receipt of the same. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that Mr. Hanuman Prasad (Membership No. A46027) has tendered his resignation from the post of Company Secretary and Compliance Officer of the Company with effect from 23.06.2022 by submitting his resignation letter dated 23.06.2022 to the Board of Directors of the Company. Resignation Letter (reason of resignation mentioned within) is attached herewith for your consideration. Please take the above on records and acknowledge the receipt of the same. Genomic Valley Biotech Ltd - 539206 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31.03.2022
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure of Related Party Transactions for the half year ended 31.03.2022. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Newspaper advertisements of the Extract of Audited Financial Results for the quarter and year ended 31.03.2022 approved in Board Meeting of the Company held on 28.05.2022. Genomic Valley Biotech Ltd - 539206 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby submit the Annual Compliance Report for the Financial Year 2021-22 issued by Mr. Rohit Batham, Designated Partner of SBR & Co. LLP (LLPIN AAO-9057) (Peer Review No. 1631/2021). Genomic Valley Biotech Ltd - 539206 - Intimation Of Appointments
1. Appointment of M/s SBR & Co. LLP, Company Secretaries, New Delhi as Secretarial Auditors of the Company for the Financial Year 2021-22 2. Appointment of M/s SBR & Co. LLP, Company Secretaries, New Delhi to issue Annual Secretarial Compliance Report for the Financial Year 2021-22 as per Regulation 24A of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Genomic Valley Biotech Ltd - 539206 - Results- Financial Results For Quarter And Year Ended 31.03.2022
Intimation and disclosure under Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Audited Financial Results and Independent Auditor's Report for the quarter and year ended 31.03.2022 Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcomes Of Board Meeting
1. Intimation and disclosure under Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Audited Financial Results and Independent Auditor's Report for the quarter and year ended 31.03.2022 2. Appointment of M/s SBR & Co. LLP, Company Secretaries, New Delhi as Secretarial Auditors of the Company for the Financial Year 2021-22 3. Appointment of M/s SBR & Co. LLP, Company Secretaries, New Delhi to issue Annual Secretarial Compliance Report for the Financial Year 2021-22 as per Regulation 24A of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015